Harvard Medicine home webweekly
November 6, 2006

In Print


Bruce Spiegelman and Dimitri Krainc
Photo by Steve Gilbert/Photo Courtesy of Dimitri Krainc

From Focus:
Energy-boosting Protein May Ease Neural Oxidative Stress
A molecule better known for turbo-charging muscles and burning fat may protect brains from neurodegeneration, according to two independent studies of mice by HMS researchers. The molecule, PGC-1 alpha, revs up mitochondria, the on-demand cellular energy system. It also turns up enzymes to clean up the toxic emissions of these cellular power plants, report Bruce Spiegelman (left) and his colleagues. Further, PGC-1 alpha can worsen or protect brains in mouse models of Huntington’s disease. The mutant huntingtin gene appears to attach to the DNA upstream of the PGC-1 alpha gene and directly interfere with transcription, according to researchers in the lab of Dmitri Krainc (right).


Upcoming

Program on the Global Demography of Aging

The Age Dynamics of Voting

Monday, November 13
4:30—6 p.m.

Spotlight

Kenneth Hancock and Family
Photo by Steve Gilbert

Scholars in Medicine Marks 11th Year of Growth
The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine awarded 69 fellowships in a ceremony last month. That's 14 more than last year. Kenneth Hancock (above with family) was among the 2006 winners. Follow the link for a complete list of recipients.


Student Scene

Pursuing Discovery in Medicine
Part of the new, integrated curriculum at HMS is a course on the role of medical research. Developed by Terry Maratos-Flier and Ellen Seely, the coursework will expose students to the step-by-step process of scientific investigation. The class begins in January.


Lab Works

A multimedia site featuring Harvard Medical research.


StudenTalk

Personal takes on issues inside and outside the classroom.

Headlines

News from HMS and Its Affiliates

Novel Endogenous Lipid Compounds, Resolvins and Protectins, Protect Kidneys From Acute Renal Failure

A Potential Biological Cause for Sudden Infant Death Syndrome (SIDS)

Joslin Study Shows Durability of Insulin Pump Therapy for Adolescents and Identifies Factors to Help Them Overcome Barriers to Success

Back Issues

Online Publications

Calendar

HMS Home

InteliHealth

Contact Us